Equity Analysis /
United States of America

US : Aerie Pharmaceuticals, Inc. - AERI | Weekly Rx Metrics — Glaucoma Products Tracking to 2021 Consensus Though 2022 Less Certain

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    9 November 2021
    Published by